Stockreport

Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC [Yahoo! Finance]

Tiziana Life Sciences Ltd - Common Shares  (TLSA) 
PDF biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal an [Read more]